BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Van den Wyngaert T, Elvas F, De Schepper S, Kennedy JA, Israel O. SPECT/CT: Standing on the Shoulders of Giants, It Is Time to Reach for the Sky! J Nucl Med 2020;61:1284-91. [PMID: 32620702 DOI: 10.2967/jnumed.119.236943] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Zha Y, Liu L, Liao A, Dong Z, Roberts N, Li Y. Single photon emission computed tomography/computed tomography imaging of gouty arthritis: A new voice. Journal of Translational Internal Medicine 2023;0. [DOI: 10.2478/jtim-2022-0066] [Reference Citation Analysis]
2 Huh Y, Caravaca J, Kim J, Cui Y, Huang Q, Gullberg G, Seo Y. Simulation studies of a full-ring, CZT SPECT system for whole-body imaging of (99m) Tc and (177) Lu. Med Phys 2023. [PMID: 36916755 DOI: 10.1002/mp.16360] [Reference Citation Analysis]
3 Chernov V, Rybina A, Zelchan R, Medvedeva A, Bragina O, Lushnikova N, Doroshenko A, Usynin E, Tashireva L, Vtorushin S, Abouzayed A, Rinne SS, Sörensen J, Tolmachev V, Orlova A. Phase I Trial of [99mTc]Tc-maSSS-PEG2-RM26, a Bombesin Analogue Antagonistic to Gastrin-Releasing Peptide Receptors (GRPRs), for SPECT Imaging of GRPR Expression in Malignant Tumors. Cancers 2023;15:1631. [DOI: 10.3390/cancers15061631] [Reference Citation Analysis]
4 Hagio T, Moody JB, Poitrasson-Rivière A, Renaud JM, Pierce L, Buckley C, Ficaro EP, Murthy VL. Multi-center, multi-vendor validation of deep learning-based attenuation correction in SPECT MPI: data from the international flurpiridaz-301 trial. Eur J Nucl Med Mol Imaging 2023;50:1028-33. [PMID: 36401636 DOI: 10.1007/s00259-022-06045-8] [Reference Citation Analysis]
5 Gherghe M, Mutuleanu MD, Stanciu AE, Irimescu I, Lazar AM, Toma RV, Trifanescu OG, Anghel RM. Quantitative Assessment of Treatment Response in Metastatic Breast Cancer Patients by SPECT-CT Bone Imaging-Getting Closer to PET-CT. Cancers (Basel) 2023;15. [PMID: 36765651 DOI: 10.3390/cancers15030696] [Reference Citation Analysis]
6 Gherghe M, Lazar AM, Simion L, Irimescu IN, Sterea MC, Mutuleanu MD, Anghel RM. Standardized Uptake Values on SPECT/CT: A Promising Alternative Tool for Treatment Evaluation and Prognosis of Metastatic Neuroendocrine Tumours. Diagnostics (Basel) 2023;13. [PMID: 36673128 DOI: 10.3390/diagnostics13020318] [Reference Citation Analysis]
7 Jiang Y, Fang S, Feng J, Ruan Q, Zhang J. Synthesis and Bioevaluation of Novel Technetium-99m-Labeled Complexes with Norfloxacin HYNIC Derivatives for Bacterial Infection Imaging. Mol Pharm 2023;20:630-40. [PMID: 36398935 DOI: 10.1021/acs.molpharmaceut.2c00830] [Reference Citation Analysis]
8 Man F, Tang J, Swedrowska M, Forbes B, T M de Rosales R. Imaging drug delivery to the lungs: Methods and applications in oncology. Adv Drug Deliv Rev 2023;192:114641. [PMID: 36509173 DOI: 10.1016/j.addr.2022.114641] [Reference Citation Analysis]
9 Yin G, Ruan Q, Jiang Y, Zhang J. Radiolabeling and Biological Evaluation of Novel (99m)Tc-Nitrido and (99m)Tc-Oxo Complexes with 4-Methoxy-(L)-Phenylalanine Dithiocarbamate for Tumor Imaging. Pharmaceutics 2022;14. [PMID: 36297631 DOI: 10.3390/pharmaceutics14102196] [Reference Citation Analysis]
10 Shu Z, Lei J, Ding C. Diagnostic Value Comparison between Multislice Spiral Computerized Tomography and Magnetic Resonance Imaging under Artificial Intelligence Algorithm in Diagnosing Occult Fractures of the Knee Joint. Contrast Media Mol Imaging 2022;2022:3282409. [PMID: 36247848 DOI: 10.1155/2022/3282409] [Reference Citation Analysis]
11 Takalloobanafshi G, Kukreja A, Hicks JW. Historical efforts to develop 99mTc-based amyloid plaque targeting radiotracers. Front Nucl Med 2022;2. [DOI: 10.3389/fnume.2022.963698] [Reference Citation Analysis]
12 Xiao D, Jiang Y, Feng J, Ruan Q, Wang Q, Yin G, Zhang J. Novel 99mTc labeled complexes with bisphosphonate isocyanide: radiosynthesis and evaluation as potential bone-seeking agents. Bioorganic & Medicinal Chemistry Letters 2022. [DOI: 10.1016/j.bmcl.2022.128918] [Reference Citation Analysis]
13 Xu L, Wang L, Chen H, Wang X, Chen F, Lyu B, Hang W, Zhao W, Yuan J. Effects of pH Values and H2O2 Concentrations on the Chemical Enhanced Shear Dilatancy Polishing of Tungsten. Micromachines 2022;13:762. [DOI: 10.3390/mi13050762] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
14 Vermeulen I, Isin EM, Barton P, Cillero-pastor B, Heeren RM. Multimodal molecular imaging in drug discovery and development. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.04.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Liu T, Wu Y, Shi L, Li L, Hu B, Wang Y, Gao H, Yu X, Zhang X, Zhao H, Wan Y, Jia B, Wang F. Preclinical evaluation of [99mTc]Tc-labeled anti-EpCAM nanobody for EpCAM receptor expression imaging by immuno-SPECT/CT. Eur J Nucl Med Mol Imaging 2022. [PMID: 35013776 DOI: 10.1007/s00259-021-05670-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Mendoza-ibañez OI, Martínez-lucio TS, Alexanderson-rosas E, Slart RH. SPECT in Ischemic Heart Diseases. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00015-6] [Reference Citation Analysis]
17 Zanzonico P. Instrumentation for Single-Photon Emission Computed Tomography (SPECT). Nuclear Oncology 2022. [DOI: 10.1007/978-3-319-26067-9_5-2] [Reference Citation Analysis]
18 Kim EE, Murad V, Paeng J, Im H, Kim J, Cheon G. Atlas and Anatomy of SPECT/CT. Atlas and Anatomy of PET/MRI, PET/CT and SPECT/CT 2022. [DOI: 10.1007/978-3-030-92349-5_3] [Reference Citation Analysis]
19 Imbert L, Bahloul A, Verger A, Marie P. 360° CZT gamma cameras for nuclear medicine and molecular imaging. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00087-9] [Reference Citation Analysis]
20 Van den Wyngaert T. Gamma camera imaging (bone scan) in orthopedics: Foot, ankle, knees, and hip. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00214-3] [Reference Citation Analysis]
21 Bukowska-Olech E, Trzebiatowska W, Czech W, Drzymała O, Frąk P, Klarowski F, Kłusek P, Szwajkowska A, Jamsheer A. Hereditary Multiple Exostoses-A Review of the Molecular Background, Diagnostics, and Potential Therapeutic Strategies. Front Genet 2021;12:759129. [PMID: 34956317 DOI: 10.3389/fgene.2021.759129] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Kennedy J, Chicheportiche A, Keidar Z. Quantitative SPECT/CT for dosimetry of peptide receptor radionuclide therapy. Semin Nucl Med 2021:S0001-2998(21)00091-X. [PMID: 34911637 DOI: 10.1053/j.semnuclmed.2021.11.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 De Schepper S, Gnanasegaran G, Dickson JC, Van den Wyngaert T. Absolute Quantification in Diagnostic SPECT/CT: The Phantom Premise. Diagnostics (Basel) 2021;11:2333. [PMID: 34943570 DOI: 10.3390/diagnostics11122333] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
24 Zhu M, Shi Y, Shan Y, Guo J, Song X, Wu Y, Wu M, Lu Y, Chen W, Xu X, Tang L. Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics. J Nanobiotechnology 2021;19:387. [PMID: 34819084 DOI: 10.1186/s12951-021-01131-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
25 Taiwo OJ, Orunmuyi AT. Maximal covering location problem for nuclear medicine clinics allocation in Nigeria. Spat Inf Res 2021;29:919-35. [DOI: 10.1007/s41324-021-00405-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Fang S, Jiang Y, Xiao D, Zhang X, Gan Q, Ruan Q, Zhang J. Synthesis and Evaluation of Novel Norfloxacin Isonitrile 99mTc Complexes as Potential Bacterial Infection Imaging Agents. Pharmaceutics 2021;13:518. [PMID: 33918583 DOI: 10.3390/pharmaceutics13040518] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Harmand TJ, Islam A, Pishesha N, Ploegh HL. Nanobodies as in vivo, non-invasive, imaging agents. RSC Chem Biol 2021;2:685-701. [PMID: 34212147 DOI: 10.1039/d1cb00023c] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
28 Abouzayed A, Rinne SS, Sabahnoo H, Sörensen J, Chernov V, Tolmachev V, Orlova A. Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer. Pharmaceutics 2021;13:182. [PMID: 33573232 DOI: 10.3390/pharmaceutics13020182] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
29 Bakos G, Roscher M, Granados SM, Benešová M. Radiotracer zur Diagnose des Prostatakarzinoms: Etablierte und neue Verfahren. Der Nuklearmediziner 2020;43:275-288. [DOI: 10.1055/a-1108-7061] [Reference Citation Analysis]
30 Orunmuyi AT, Lawal IO, Omofuma OO, Taiwo OJ, Sathekge MM. Underutilisation of nuclear medicine scans at a regional hospital in Nigeria: need for implementation research. Ecancermedicalscience 2020;14:1093. [PMID: 33014135 DOI: 10.3332/ecancer.2020.1093] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]